The Effect of Microbiome-Derived Metabolites in Inflammation-Related Cancer Prevention and Treatment
Biomolecules · 08.05.2025 · 15 (5) · 688
DOI: 10.3390/biom15050688 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 08.05.2025. Verfasst von Alice N Mafe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Faculty of Sciences, Taraba State University, Main Campus, Jalingo 660101, Taraba State, Nigeria. Hauptthemen laut MEDLINE: Neoplasms, Inflammation, Microbiota. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Research Fund, Qatar Foundation.
Abstract (Originalsprache)
Chronic inflammation plays a crucial role in cancer development, yet the mechanisms linking the microbiome to inflammation-related carcinogenesis remain unclear. Emerging evidence suggests that microbiome-derived metabolites influence inflammatory pathways, presenting both challenges and opportunities for therapy. However, a deeper understanding of how these metabolites regulate inflammation and contribute to cancer prevention is still needed. This review explores recent advances in microbiome-derived metabolites and their roles in inflammation-related carcinogenesis. It highlights key molecular mechanisms, emerging therapies, and unresolved challenges. Synthesizing current research, including clinical trials and experimental models, bridges the gap between microbiome science and cancer therapy. Microbial metabolites such as short-chain fatty acids (SCFAs), polyamines, indoles, and bile acids play vital roles in regulating inflammation and suppressing cancer. Many metabolites exhibit potent anti-inflammatory and immunomodulatory effects, demonstrating therapeutic potential. Case studies show promising results, but challenges such as metabolite stability, bioavailability, and individual variability remain. Understanding microbiome–metabolite interactions offers novel strategies for cancer prevention and treatment. This review identifies knowledge gaps and proposes future research directions to harness microbiome-derived metabolites for innovative cancer therapies. Addressing these issues may pave the way for microbiome-targeted cancer interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Faculty of Sciences, Taraba State University, Main Campus, Jalingo 660101, Taraba State, Nigeria.
- Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha Metropolitan Area, Al Rayyan P.O. Box 22104, Qatar.
ORCID-Profile: Alice N Mafe, Dietrich Büsselberg
Förderung
- Qatar National Research Fund
- Qatar Foundation
Zitieren
APA
Mafe, A. N., & Büsselberg, D. (2025). The Effect of Microbiome-Derived Metabolites in Inflammation-Related Cancer Prevention and Treatment. Biomolecules, 15(5), 688. https://doi.org/10.3390/biom15050688
Vancouver
Mafe AN, Büsselberg D. The Effect of Microbiome-Derived Metabolites in Inflammation-Related Cancer Prevention and Treatment. Biomolecules. 2025;15(5):688. doi:10.3390/biom15050688
BibTeX
@article{Mafe2025,
author = {Mafe, Alice N and Büsselberg, Dietrich},
title = {The Effect of Microbiome-Derived Metabolites in Inflammation-Related Cancer Prevention and Treatment},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {5},
pages = {688},
doi = {10.3390/biom15050688}
}
EUVIMED